These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1989164)

  • 1. Immunosuppressive activity of deflazacort vs methylprednisolone in renal transplantation: effects on lymphocyte subsets.
    Elli A; Rivolta R; Mascaretti L; Parenti M; Palazzi P; Quarto Di Palo F; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1122-4. PubMed ID: 1989164
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation--immunosuppressive activity and side effects.
    Elli A; Rivolta R; Di Palo FQ; Parenti M; Vergallo G; Palazzi P; Zafiropulu S; Abelli P; Zanussi C
    Transplantation; 1993 Jan; 55(1):209-12. PubMed ID: 8420051
    [No Abstract]   [Full Text] [Related]  

  • 3. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
    Elli A; Rivolta R; Palazzi P; Mascaretti L; Puglisi G; Parenti M; Sioli V; Di Palo FQ
    Transplant Proc; 1990 Aug; 22(4):1689-90. PubMed ID: 2202126
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
    Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich AM; Jasper H;
    Pediatr Nephrol; 2007 May; 22(5):734-41. PubMed ID: 17294225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiles with triple drug immunosuppressive therapy and with double drug combinations after renal transplantation and stable graft function.
    Isoniemi H; Tikkanen M; Häyry P; Eklund B; Höckerstedt K; Salmela K; Ahonen J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1029-31. PubMed ID: 1989148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
    Oesterwitz H; Strobelt V; May G; Horlbeck R
    Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
    De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
    Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of donor-specific regulatory T-cell function in kidney transplant patients.
    Hendrikx TK; van Gurp EA; Sewgobind VD; Mol WM; Schoordijk W; Klepper M; Velthuis JH; Geel A; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2009 Feb; 87(3):376-83. PubMed ID: 19202442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basic immunosuppressive therapy following kidney transplantation. Cyclosporin A in combination with small doses of methylprednisolone, without regard to selection criteria. Preliminary report].
    Land W; Castro LA; Hillebrand G; Illner WD; Schneider B; Siebert W; Zink R; Albert E
    Fortschr Med; 1982 Nov; 100(41):1912-6. PubMed ID: 6759336
    [No Abstract]   [Full Text] [Related]  

  • 13. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

  • 16. CD4+/CD8+ lymphocyte patterns in renal transplant recipients receiving chronic methylprednisolone.
    Tornatore KM; Reed K; Venuto RC
    J Med; 1993; 24(2-3):98-112. PubMed ID: 8105017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of different T and B-peripheral blood lymphocyte subsets in liver transplantation after cyclosporine or OKT3 immunosuppressive treatment.
    Minguela A; Alvarez-López MR; Sánchez-Bueno F; Torío A; Muro M; Robles R; Pons JA; Parrilla P; García-Alonso AM
    Transplant Proc; 1995 Aug; 27(4):2317-8. PubMed ID: 7652825
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract]   [Full Text] [Related]  

  • 19. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Portalupi V; Adamo G; Soccio G; Dal Canton A
    Transplant Proc; 2006 Nov; 38(9):2893-4. PubMed ID: 17112857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.